Topics

Articles

As the number of adverse events (AEs) grows year by year, regulators and industry managers are looking at automated systems to handle the burden

In an EHR era, adverse event reporting takes on a new look

Pricing systems in US drug supply chain have many limitations; an analytics-based method might avoid some of them

Analyzing drug-pricing mechanisms

New incentives for health plans could alter the way payers review new drugs

Medicare Star ratings: the billion-dollar opportunity for providers

As payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical

Ensuring the quality of comparative effectiveness research

New sample reporting requirements will be a focus of this year's meeting

2012 PDMA Sharing Conference preview

Despite the lack of headlines today as compared to late last year, the drug-shortage situation has not improved. FDA, congressional and industry actions are beginning to change the dynamic

Drug shortages 2012: a worsening situation, but movement on industry response

The pioneering firms that installed serialization and track-and-trace systems are being joined by a fast follower crowd, but an industry-wide commitment is still in the future

Manufacturers are reviving their serialization plans

The 'Sunshine Act' provisions of the Affordable Care Act require records to be kept beginning Jan. 1

Aggregate Spending Rules Arrive, But Industry Is Still Gearing Up

A combination of regulatory processes and business practices are worsening an already-bad drug shortage situation

Drug Shortages Continue To Rise, With No Near-Term Resolution

Google and other web search engines have already tightened their controls for online pharmacy advertising; now they know the penalty for not doing so

Legal and Regulatory